This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
September 01, 2015
VAXIN CHANGES COMPANY NAME TO ALTIMMUNE
August 31, 2015
Trimb acquires YouMedical to build North European OTC platform
August 31, 2015
Cortendo Announces Filing of Registration Statement for Proposed Initial Public Offering
August 28, 2015
Interim Report second quarter and first half year 2015
August 26, 2015
NORDIC NANOVECTOR: RESULTS FOR THE SECOND QUARTER AND HALF YEAR 2015
August 25, 2015
Cerenis Therapeutics announces its results for the first half of 2015.
August 20, 2015
Nordic Nanovector ASA to present at Pareto Securities’ 6th Annual Health Care Seminar
August 11, 2015
Key Technology Patent Granted for US
August 11, 2015
U.S. FDA Approves ZUBSOLV® for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence
August 10, 2015
BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma